4 mg ETH 268 (Doxazosin 4 mg)

Pill imprint 4 mg ETH 268 has been identified as Doxazosin mesylate 4 mg.

Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 4 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 4 mg ETH 268

Doxazosin mesylate 4 mg 4 mg ETH 268
Doxazosin mesylate
Imprint:
4 mg
ETH 268
Strength:
4 mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Ethex Corporation
National Drug Code (NDC):
58177-0268
Inactive Ingredients:
hydrated alumina
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate
D&C Red No. 27 Aluminum Lake
D&C Red No. 30 Aluminum Lake
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
67253-0382 DAVA Pharmaceuticals, Inc.
54569-5170 A S Medication Solutions LLC (repackager)
68115-0122 Dispensexpress Inc (repackager)
58016-0625 Southwood Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)